blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3091976

EP3091976 - AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  20.06.2024
Database last updated on 09.07.2024
FormerGrant of patent is intended
Status updated on  22.02.2024
FormerExamination is in progress
Status updated on  26.03.2019
Most recent event   Tooltip05.07.2024Change - divisional application(s)published on 07.08.2024 [2024/32]
Applicant(s)For all designated states
Avalyn Pharma Inc.
701 Pike Street, Suite 1500
Seattle, WA 98101 / US
[2023/46]
Former [2020/34]For all designated states
Avalyn Pharma Inc.
12670 High Bluff Drive
San Diego, CA 92130 / US
Former [2016/46]For all designated states
Genoa Pharmaceuticals Inc.
12670 High Bluff Drive
San Diego, CA 92130 / US
Inventor(s)01 / SURBER, Mark, William
3773 Wellborn Street
San Diego, CA 92103 / US
 [2016/46]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2024/30]
Former [2016/46]Cummings, Ross Martin, et al
Avidity IP
Broers Building
Hauser Forum
21 J.J. Thomson Avenue
Cambridge CB3 0FA / GB
Application number, filing date15735018.209.01.2015
[2016/46]
WO2015US10890
Priority number, dateUS201461925791P10.01.2014         Original published format: US 201461925791 P
US201461951686P12.03.2014         Original published format: US 201461951686 P
US201461977529P09.04.2014         Original published format: US 201461977529 P
US201462000473P19.05.2014         Original published format: US 201462000473 P
[2016/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015106150
Date:16.07.2015
Language:EN
[2015/28]
Type: A1 Application with search report 
No.:EP3091976
Date:16.11.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 16.07.2015 takes the place of the publication of the European patent application.
[2016/46]
Type: B1 Patent specification
No.:EP3091976
Date:24.07.2024
Language:EN
[2024/30]
Search report(s)International search report - published on:US16.07.2015
(Supplementary) European search report - dispatched on:EP11.09.2017
ClassificationIPC:A61P9/12, A61P11/00, A61P35/00, A61K9/00, A61K31/4418, A61K31/573, A61K47/02, A61K47/12
[2024/11]
CPC:
A61K31/573 (EP,US); A61K31/4418 (EP,US); A61K47/02 (EP,US);
A61K47/12 (EP,US); A61K9/0078 (EP,US); A61M11/001 (US);
A61M11/005 (US); A61M11/02 (US); A61P11/00 (EP);
A61P35/00 (EP); A61P9/12 (EP) (-)
Former IPC [2017/41]A61K31/4418, A61K47/02, A61K47/12, A61K9/00, A61M11/00, A61M11/02, A61K31/573
Former IPC [2016/46]A61K31/4418
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/46]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:AEROSOLFÖRMIGE PIRFENIDON- UND PYRIDONANALOGVERBINDUNGEN UND VERWENDUNGEN DAVON[2016/46]
English:AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF[2016/46]
French:COMPOSÉS ANALOGUES DE PYRIDONE ET DE PIRFÉNIDONE EN AÉROSOL, ET LEURS UTILISATIONS[2016/46]
Entry into regional phase08.08.2016National basic fee paid 
08.08.2016Search fee paid 
08.08.2016Designation fee(s) paid 
08.08.2016Examination fee paid 
Examination procedure08.08.2016Examination requested  [2016/46]
09.04.2018Amendment by applicant (claims and/or description)
29.03.2019Despatch of a communication from the examining division (Time limit: M06)
17.01.2020Reply to a communication from the examining division
29.09.2020Despatch of a communication from the examining division (Time limit: M06)
03.05.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.07.2021Reply to a communication from the examining division
25.04.2023Despatch of a communication from the examining division (Time limit: M06)
06.11.2023Reply to a communication from the examining division
23.02.2024Communication of intention to grant the patent
18.06.2024Fee for grant paid
18.06.2024Fee for publishing/printing paid
18.06.2024Receipt of the translation of the claim(s)
Divisional application(s)EP24186102.0
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
13.07.2021Request for further processing filed
13.07.2021Full payment received (date of receipt of payment)
Request granted
22.07.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
17.01.2020Request for further processing filed
17.01.2020Full payment received (date of receipt of payment)
Request granted
28.01.2020Decision despatched
Fees paidRenewal fee
27.01.2017Renewal fee patent year 03
15.01.2018Renewal fee patent year 04
15.01.2019Renewal fee patent year 05
14.01.2020Renewal fee patent year 06
13.01.2021Renewal fee patent year 07
17.12.2021Renewal fee patent year 08
14.12.2022Renewal fee patent year 09
14.12.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2012192861  (SURBER MARK WILLIAM [US])
International search[X]US2013310424  (SURBER MARK WILLIAM [US])
by applicantUS3839346
 US3974281
 US4042699
 US4052509
 US4857311
 EP0347779
 US5310562
 US5518729
 US5716632
 US5785049
 US6090822
 US2006276483
 US2007092488
 US2009005424
 US8022087
 US2014094456
 WO2014055548
 US2014107110
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.